Associated Papers
Metabolic gene polymorphisms and type 2 diabetes mellitus risk: A systematic review and meta-analyses.
Indarto D et al.
Experimental and Therapeutic Medicine, 2026
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification.
Lagou V et al.
Nature Genetics, 2023
Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study.
Guan Z et al.
European Journal of Clinical Pharmacology, 2022
Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells.
Fang Z et al.
International Journal of Molecular Sciences, 2020
rs6923761 gene variant in glucagon-like peptide 1 receptor: Allelic frequencies and influence on cardiovascular risk factors in a multicenter study of Castilla-Leon.
de Luis DA et al.
Clinical Nutrition (edinburgh, Scotland), 2018
Relation of the rs6923761 gene variant in glucagon-like peptide 1 receptor with weight, cardiovascular risk factor, and serum adipokine levels in obese female subjects.
de Luis DA et al.
Journal of Clinical Laboratory Analysis, 2015
Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naïve type 2 diabetic patients.
de Luis DA et al.
Journal of Endocrinological Investigation, 2015
Polymorphisms of GLP-1 receptor gene and response to GLP-1 analogue in patients with poorly controlled type 2 diabetes.
Lin CH et al.
Journal of Diabetes Research, 2015
Association between Genetic Variants and Diabetes Mellitus in Iranian Populations: A Systematic Review of Observational Studies.
Khodaeian M et al.
Journal of Diabetes Research, 2015
Effect of rs6923761 gene variant of glucagon-like peptide 1 receptor on metabolic response and weight loss after a 3-month intervention with a hypocaloric diet.
de Luis DA et al.
Journal of Endocrinological Investigation, 2014
Cardiovascular risk factors and adipocytokines levels after two hypocaloric diets with different fat distribution in obese subjects and rs6923761 gene variant of glucagon-like peptide 1 receptor.
de Luis DA et al.
Journal of Endocrinological Investigation, 2014
[Roles of rs 6923761 gene variant in glucagon-like peptide 1 receptor on weight, cardiovascular risk factor and serum adipokine levels in morbid obese patients].
de Luis DA et al.
Nutricion Hospitalaria, 2014
Relation of the rs6923761 gene variant in glucagon-like peptide 1 receptor to metabolic syndrome in obese subjects.
de Luis DA et al.
Annals of Nutrition & Metabolism, 2014
Role of the rs6923761 gene variant in glucagon-like peptide 1 receptor gene on cardiovascular risk factors and weight loss after biliopancreatic diversion surgery.
de Luis DA et al.
Annals of Nutrition & Metabolism, 2014
Evaluation of weight loss and adipocytokine levels after two hypocaloric diets with different macronutrient distribution in obese subjects with the rs6923761 gene variant of glucagon-like peptide 1 receptor.
de Luis DA et al.
Annals of Nutrition & Metabolism, 2013
Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.
Mannino GC et al.
Molecular Diagnosis & Therapy, 2012
Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
Coopman K et al.
Molecular Endocrinology (baltimore, Md.), 2011
Spatial approximations between residues 6 and 12 in the amino-terminal region of glucagon-like peptide 1 and its receptor: a region critical for biological activity.
Chen Q et al.
The Journal of Biological Chemistry, 2010
Pharmacological characterization of human incretin receptor missense variants.
Fortin JP et al.
The Journal of Pharmacology and Experimental Therapeutics, 2010
A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness.
Beinborn M et al.
Regulatory Peptides, 2005
Five missense mutations in glucagon-like peptide 1 receptor gene in Japanese population.
Tokuyama Y et al.
Diabetes Research and Clinical Practice, 2004
Evaluation of weight loss and metabolic changes in diabetic patients treated with liraglutide, effect of RS 6923761 gene variant of glucagon-like peptide 1 receptor.
de Luis DA et al.
Journal of Diabetes and Its Complications, 0